ClinicalTrials.Veeva

Menu
Cullman Clinical Trials | Cullman, AL logo

Cullman Clinical Trials | Cullman, AL

Research site

Site insights

Top conditions

Top treatments

S-217622
Eloralintide
LY3841136
Cenicriviroc
AXA1125
Semaglutide
Bupropion Hydrochloride
BMS-963272
SAB-185
PF-07817883

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Active trials

12 of 42 total trials

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023) (MOVe-NOW)

Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most often causes mild flu or cold-like symp...

Enrolling
Coronavirus Disease (COVID-19)
Drug: Placebo
Drug: Molnupiravir

This study compares insulin icodec, an insulin taken once a week to insulin glargine, an insulin taken once a day. The study medicine will be investi...

Active, not recruiting
Diabetes Mellitus, Type 1
Drug: Insulin glargine
Drug: Insulin icodec

The main purpose of this study is to evaluate the efficacy and safety of eloralintide compared with placebo for body weight reduction in participants...

Enrolling
Overweight
Obesity
Drug: Eloralintide
Drug: Placebo

The purpose of the studies is to evaluate the efficacy and safety of eloralintide in participants with moderate-to-severe obstructive sleep apnea and...

Enrolling
Overweight
Sleep Apnea, Obstructive
Drug: Placebo
Drug: Eloralintide

The purpose of this study is to evaluate the efficacy and safety of mRNA-1283 and mRNA-1273 (variant formulations) in adults 50 to 64 years of age wi...

Active, not recruiting
SARS-CoV-2
Biological: mRNA-1283
Biological: mRNA-1273
Status recently updated

Approximately one billion cases of seasonal influenza occur annually. Of these, 3 to 5 million illnesses are severe and responsible for up to 650,000...

Active, not recruiting
Enrolling
Influenza
Combination Product: MK-1406
Combination Product: Placebo

The primary objectives of this study are to evaluate the safety and reactogenicity of mRNA-1403, and to demonstrate the efficacy of mRNA-1403 to prev...

Active, not recruiting
Acute Gastroenteritis
Norovirus Acute Gastroenteritis
Biological: mRNA-1403
Biological: Placebo

This study is being done to learn about the safety and effects of a study medicine called berobenatide (bear-oh-BEN-uh-tide). The study will see if b...

Enrolling
Sleep Disorders
Overweight and/or Obesity
Other: Placebo
Drug: Berobenatide
Status recently updated

This study is researching an experimental drug called alirocumab, referred to as "study drug". In the United States, alirocumab is approved for the t...

Enrolling
Active, not recruiting
Hypercholesterolemia
Drug: Alirocumab

This study is researching experimental drugs called trevogrumab and garetosmab (called "study drugs") in combination with another drug, semaglutide (...

Active, not recruiting
Obesity
Drug: Matching Placebo-Trevogrumab
Drug: Matching Placebo-Garetosmab

A randomized, double-blinded, placebo controlled study intended to capture cardiovascular outcomes during real-world use of naltrexone/bupropion (NB).

Active, not recruiting
Obesity
Drug: Placebo
Drug: Naltrexone-Bupropion (NB) Combination

The purpose of this study is to evaluate the efficacy, safety, and tolerability of VX-993 in participants with pain associated with Diabetic Peripher...

Enrolling
Diabetic Peripheral Neuropathic Pain
Drug: Placebo (matched to pregabalin)
Drug: Placebo (matched to VX-993)

Trial sponsors

Lilly logo
Moderna logo
Pfizer logo
Exact Sciences Corporation logo
Gilead Sciences logo
L
Regeneron Pharmaceuticals logo
Shionogi logo
C
A

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems